John Chad Brenner

26PUBLICATIONS
63CO-AUTHORS
Cancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 20, 2026
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial.

Alexander T Pearson, Jameel Muzaffar, Kedar Kirtane

|Dec 12, 2025
FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial.

Michelle Mierzwa, Benjamin Rosen, Krithika Suresh

|Nov 03, 2025
Asymmetric integration of various cancer datasets for identifying risk-associated variants and genes.

Ruixuan Wang, Lam Tran, Benjamin Brennan

|Jul 21, 2025
Genomic Signatures of Poor Prognosis in Merkel Cell Carcinoma: A Single-Institution Prospective Study.

Joshua D Smith, Apurva D Bhangale, Wenjin Gu

Pageof 5